Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Do Cao

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Endocrine|March 10, 2020
Locally unresectable differentiated thyroid cancer: outcomes and perspectivesL Lamartina, Y Godbert, C Nascimento, et al.
Annales D'Endocrinologie|June 7, 2011
Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular originL Leenhardt, F Borson-Chazot, M Calzada, et al.
Endocrine-Related Cancer|November 8, 2018
French Endocrine Society Guidance on endocrine side effects of immunotherapyF Castinetti, F Albarel, F Archambeaud, et al.
ESMO Open|March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RETJ Hadoux, J Hernando, K H Wong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Endocrine|March 10, 2020
Locally unresectable differentiated thyroid cancer: outcomes and perspectivesL Lamartina, Y Godbert, C Nascimento, et al.
Annales D'Endocrinologie|June 7, 2011
Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular originL Leenhardt, F Borson-Chazot, M Calzada, et al.
Endocrine-Related Cancer|November 8, 2018
French Endocrine Society Guidance on endocrine side effects of immunotherapyF Castinetti, F Albarel, F Archambeaud, et al.
ESMO Open|March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RETJ Hadoux, J Hernando, K H Wong, et al.
Pageof 2